Definium says LSD-based pill reduces anxiety in late-stage study - Reuters
Definium says LSD-based pill reduces anxiety in late-stage study Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxNaVJtXzlnUVdYbzdUUzhnSmFFSFB6dm9sNS0wdi1WMjZWc1JvZVlXdVFHcmNZUGROUi1ZcDAxYWl4TlQ5dWJGUGZycHFnLWRvS0xOcTlNWW5VYlU3Y09DT3g2ZDNqNDJrS0p1LTBrSTRzR1VXMkdROTRZeWVHQ2F5QWJyQ0tvS0xacmVSMENrdDVnWUZwa3JDcmNUb0xaM0gzbU1CaW9pUEpRR2N1bUszUnZGVFlPcHNiM3VPVk9mTjBjdEFKc2gyWVFVd2xydw?oc=5" target="_blank">Definium says LSD-based pill reduces anxiety in late-stage study</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Lilly's experimental drug cuts weight by 21% in diabetes trial - reuters.com
Lilly's experimental drug cuts weight by 21% in diabetes trial reuters.com
September 29, 2026 at 10:15 PMExperimental Lilly combination drug tops Zepbound in weight-loss trial - Reuters
Experimental Lilly combination drug tops Zepbound in weight-loss trial Reuters
September 30, 2026 at 05:34 PMUniQure plunges as Huntington's trial data disappoints investors - reuters.com
UniQure plunges as Huntington's trial data disappoints investors reuters.com
September 29, 2026 at 10:11 PMUS FDA approves AbbVie's drug for Parkinson's disease - reuters.com
US FDA approves AbbVie's drug for Parkinson's disease reuters.com
September 25, 2026 at 10:57 PMNovo Nordisk to license experimental GLP-1 pill from China's Hengrui - Reuters
Novo Nordisk to license experimental GLP-1 pill from China's Hengrui Reuters
September 29, 2026 at 04:47 AMAstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination - Reuters
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination Reuters
October 2, 2026 at 06:58 AM